AqT® ADC Platform

Breakthrough AqueaTether® (AqT®) Platform
                                                                                                           for Drug Conjugation and Delivery

AqT® linkers are novel biomaterials derived from edible sugar alcohols, such as mannitol.
They are super-hydrophilic, highly water-soluble, and feature versatile structures that can be easily customized for any AqT® Therapeutics.

      • Adjustable linker
      • Flexible linkage chemistry enabling controlled drug release
      • High drug loading capacity

AqT platform target

AqT platform aims to solve a fundamental challenge in drug delivery:
Making powerful medicines work better in the body by maintaining their stability during delivery.
AqT collaboration

We collaborate directly with our customers to improve and develop their drugs.

The first and only company in the sugar alcohol IP space, ensuring freedom of operation.
issued and allowed patents worldwide covering the broad composition matter of AqT platform
Won FY14 DoD Breast Cancer Research Program Breakthrough Award for precision medicine.